Concepedia

Jay H. Kalin

JH

Statistics

Publications

21

Citations

2.4K

H-Index

19

Active since

2006

Affiliations

University of Illinois Chicago(Current)

Johns Hopkins University

Brigham and Women's Hospital

Harvard University

Johns Hopkins Medicine

Jay H. Kalin is an author at University of Illinois Chicago specializing in medicine, cell biology, and natural sciences.

ORCID

Top concepts

Publications per year

2006–2024

21

Publications

21

Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A

Kyle V. Butler, Jay H. Kalin, Camille Brochier et al. · Journal of the American Chemical Society · 2010 · 755 citations · Full text

, , +16

Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors

Jay H. Kalin, Muzhou Wu, Andrea V. Gómez et al. · Nature Communications · 2018 · 228 citations · Full text

Re-programing Chromatin with a Bifunctional LSD1/HDAC Inhibitor Induces Therapeutic Differentiation in DIPG

Jamie N. Anastas, Barry M. Zee, Jay H. Kalin et al. · Cancer Cell · 2019 · 180 citations · Full text

, , +10

RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells

Brian Budke, Hillary L. Logan, Jay H. Kalin et al. · Nucleic Acids Research · 2012 · 176 citations · Full text

, , +12

Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition

Maj-Linda B. Selenica, Leif Benner, Steven B. Housley et al. · Alzheimer s Research & Therapy · 2014 · 130 citations · Full text

1–5 of 21